EMCDDA Home
  • EN
Search

Table TDI-111. Frequency of use of primary drug of clients entering outpatient treatment, 2011 or most recent year available

Part (iii) New cocaine (HCI and ‘crack’) outpatient clients by country and frequency of use (%)

CountryNot used in the past month/ OccasionalOnce a week or less2 - 6 times per weekDailyFrequency known (n) Frequency unknown
Belgium53.111.526.58.822620
Bulgaria33.333.333.330
Czech Republic66.733.360
Denmark33.351.515.26615
Germany
Estonia
Ireland124.817.352.25.82786
Greece30.426.123.220.3690
Spain120.722.135.521.796042544
France26.315.624.233.942255
Italy219.931.423.625.15969969
Cyprus29.212.525.033.3240
Latvia310010
Lithuania
Luxembourg
Hungary76.211.99.52.4421
Malta17.319.226.936.552
Netherlands29.012.832.226.1870504
Austria34.220.520.524.7738
Poland4
Portugal530.59.625.734.124910
Romania100.011
Slovenia28.614.342.914.371
Slovakia33.333.333.360
Finland00
Sweden128.614.342.914.370
United Kingdom6
Croatia70.411.114.83.7270
Turkey
Norway
Total21.824.231.023.0180024134
 

Notes:

: Indicates no data are available.

Percentages are of clients whose frequency of use is known (n)

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

See also Table TDI-18 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013